MedPath

Does integrating a parenting support program into paediatric eczema care services improve treatment outcomes? A randomised controlled trial.

Not Applicable
Conditions
Atopic dermatitis (eczema) in children
Parenting children with atopic dermatitis (eczema)
Skin - Dermatological conditions
Registration Number
ACTRN12618001332213
Lead Sponsor
Dr Amy Mitchell
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
59
Inclusion Criteria

Parents of 2- to 10-year-old children with eczema who are currently prescribed topical corticosteroids and attending dermatology outpatient clinics at the Lady Cilento Children's Hospital (Brisbane).

Exclusion Criteria

The child has a disability, including language and speech impairment.
The parents are currently seeing a professional for the child’s behaviour difficulties.
The parents are currently receiving psychological help or counselling.
The parents have previously completed Triple P.
The parents have difficulties in reading an English newspaper.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease severity: Atopic dermatitis (eczema) severity will be assessed via visual assessment using the Eczema Area Severity Index (EASI), and via parent-report of symptom severity using the Patient Orientated Eczema Measure (POEM).[Baseline, 4 weeks post-intervention (6 weeks after baseline assessment for care as usual families), and 6 month follow-up. ];Treatment Adherence: Use of topical eczema medications, assessed using the Medication Event Monitoring System (MEMS) 6 TrackCaps.[Daily adherence will be monitored for the duration of participation in the study, beginning 1 month prior to randomisation and continuing until 6-month follow-up.]
Secondary Outcome Measures
NameTimeMethod
Parenting behaviour, as assessed using the Parenting Scale.[Baseline, 4 weeks post-intervention (6 weeks after baseline assessment for care as usual families), and 6 month follow-up. ];Atopic dermatitis (eczema) management, as assessed using the Child Eczema Management Questionnaire.[Baseline, 4 weeks post-intervention (6 weeks after baseline assessment for care as usual families), and 6 month follow-up. ];Child behaviour, as assessed using the Eczema Behaviour Checklist.[Baseline, 4 weeks post-intervention (6 weeks after baseline assessment for care as usual families), and 6 month follow-up. ];Quality of life, as assessed using the Child Dermatology Life Quality Index (child) and the Dermatitis Family Impact Questionnaire (family).[Baseline, 4 weeks post-intervention (6 weeks after baseline assessment for care as usual families), and 6 month follow-up. ]
© Copyright 2025. All Rights Reserved by MedPath